Background: Liver receptor homolog 1 (LRH-1, NR5A2) regulates functions of liver, intestines, and pancreas; its aberrant activity is associated with tumorigenesis. Results: Our work identifies the first antagonists of LRH-1.
Conclusion:The identified ligands inhibit LRH-1 transcriptional activity, diminishing expression of the receptor's target genes. Significance: LRH-1 inhibitors could be used for analyses of the receptor's biological mechanisms and for development of cancer therapeutics.